1 / 17

Receptor Binding and Kinetics NS 1, Spring 2011 Judson Chandler Office: IOP Rm 469 Ext 2-5224

Receptor Binding and Kinetics NS 1, Spring 2011 Judson Chandler Office: IOP Rm 469 Ext 2-5224 chandj@musc.edu. Pharmacological parameters define receptors Vast majority present a special problem. L. R. E. Biological Response. What are the pharmacological properties of receptors?.

Download Presentation

Receptor Binding and Kinetics NS 1, Spring 2011 Judson Chandler Office: IOP Rm 469 Ext 2-5224

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Receptor Binding and Kinetics NS 1, Spring 2011 Judson Chandler Office: IOP Rm 469 Ext 2-5224 chandj@musc.edu

  2. Pharmacological parameters define receptors Vast majority present a special problem L R E Biological Response

  3. What are the pharmacological properties of receptors? Biological Response Saturability Specificity Reversibility Additional receptors properties---Molecular Specific Binding vs non-specific binding Characterized by??

  4. Ligand Receptor Interactions Law of Mass Action K1 K2 L + R LR Effect [L] [R] K2 Kd = = K1 [LR] where, K1 = association rate constant K2 = dissociation rate constant [L] = concentration of free ligand [R] = concentration of free receptor [LR] = concentration of bound receptor Kd = dissociation equilibrium constant

  5. Since the total # of Receptors = [Rt] = [R] + [LR] rearrange [R] = [Rt] - [LR] [L] [R] Kd = combine equations [LR] [L] ([Rt] - [LR]) Kd = [LR] solve [L] [Rt] [LR] = [L] + Kd

  6. So, since the fraction of receptors occupied (r) is [LR] bound r = = [Rt] total rearrange [LR] = r Rt [L] [Rt] combine [LR] = [L] + Kd [L][Rt] r Rt = [L] + Kd solve [L] r = [L] + Kd

  7. [L] r = [L] + Kd Now, if the concentration of the ligand is varied, then a plot of r vs [L] will produce a hyperbola. This is a Langmuir plot

  8. Sigmoid dose-response curve Why plot as a log?

  9. Rosenthal-Scatchard Equation [L] r = [L] + Kd rearrange Kdr + r[L] = [L] rearrange r -r 1 = + [L] Kd Kd Scatchard plot

  10. What if scatchard plot exhibit non-linearity? E bound or log log Emax - E Rt - bound where E = effect Hill plot

  11. Before proceding, let’s define some terms: Potency = dependency of a drugs effect on it’s [ ] what is its relationship to binding affinity? Efficacy = degree of a response (i.e. maximal effect) also called Intrinsic Activity what is its relationship to binding affinity Full agonist = a drug that produces a maximal effect Partial agonist = a drug that does not ellicit an full response (even though all receptors are bound) Antagonist = a drug that has no efficacy

  12. Competitive antagonist antagonism of the agonist response can be overcome by increasing the concentration of the agonist Non-competitive antagonist increasing agonist [ ] has no effect Effects on dose-response curves

  13. If an agonist and an antagonist both bind to a receptor on the same site, how can one produce an effect and the other have no effect? Consider a receptor exist in two conformations: active (a) and inactive (i) Ri Ra DRi DRa Importance of affinity of a drug for the two conformations effect of a Full agonist vs a Partial agonist What if the drug has equal affinity for Ri and Ra? What if the drug has a preferrential affinity for Ri?

  14. Let’s see how this would look on a plot

  15. Recall the occupation theory of drug-receptor action: Response to a drug is directly proportional to the fraction of receptors occuppied. e.g. EC50 = Kd But …… what if EC50 is lower than the Kd Concept of Spare Receptors What can cause this? What if EC50 > Kd?

  16. Concept of receptor desensitization subsequent response is decreased following exposure to an agonist Desensitization vs Down-regulation Homologous vs Heterologous desensitization R1 G E second messenger R2

  17. Lastly…. Effect of GTP on displacement of binding by an agonist vs antagonist Propranolol = Beta receptor antagonist Isoproterenol = Beta receptor agonist 125I-IPIN = iodinated Beta receptor antagonist

More Related